trial · primary record
Intranasal Oxytocin 40 i.u.
Obesity & Overweight
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2030-07-14 |
| Primary endpoint | Postoperative Hypopnea Events |
| Registry ID | NCT07902752 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:49.159Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07902752
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.